Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis

Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with lo...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 21; no. 1; pp. 14 - 8
Main Authors Kondo, Yasushi, Suzuki, Katsuya, Inoue, Yumiko, Sakata, Koumei, Takahashi, Chihiro, Takeshita, Masaru, Kassai, Yoshiaki, Miyazaki, Takahiro, Morita, Rimpei, Niki, Yasuo, Kaneko, Yuko, Yasuoka, Hidekata, Yamaoka, Kunihiro, Yoshimura, Akihiko, Takeuchi, Tsutomu
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 10.01.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
AbstractList Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1[beta] and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Keywords: Ultrasonography, Rheumatoid arthritis/DG, Cytokines, Inflammation, Diagnostic imaging
Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1[beta] and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA).BACKGROUNDUltrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA).A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured.METHODSA total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured.Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity.RESULTSBoth US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity.We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.CONCLUSIONSWe demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
Abstract Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.
ArticleNumber 14
Audience Academic
Author Inoue, Yumiko
Takeuchi, Tsutomu
Yoshimura, Akihiko
Suzuki, Katsuya
Yamaoka, Kunihiro
Miyazaki, Takahiro
Kondo, Yasushi
Kaneko, Yuko
Sakata, Koumei
Takahashi, Chihiro
Kassai, Yoshiaki
Yasuoka, Hidekata
Niki, Yasuo
Takeshita, Masaru
Morita, Rimpei
Author_xml – sequence: 1
  givenname: Yasushi
  surname: Kondo
  fullname: Kondo, Yasushi
– sequence: 2
  givenname: Katsuya
  surname: Suzuki
  fullname: Suzuki, Katsuya
– sequence: 3
  givenname: Yumiko
  surname: Inoue
  fullname: Inoue, Yumiko
– sequence: 4
  givenname: Koumei
  surname: Sakata
  fullname: Sakata, Koumei
– sequence: 5
  givenname: Chihiro
  surname: Takahashi
  fullname: Takahashi, Chihiro
– sequence: 6
  givenname: Masaru
  surname: Takeshita
  fullname: Takeshita, Masaru
– sequence: 7
  givenname: Yoshiaki
  surname: Kassai
  fullname: Kassai, Yoshiaki
– sequence: 8
  givenname: Takahiro
  surname: Miyazaki
  fullname: Miyazaki, Takahiro
– sequence: 9
  givenname: Rimpei
  surname: Morita
  fullname: Morita, Rimpei
– sequence: 10
  givenname: Yasuo
  surname: Niki
  fullname: Niki, Yasuo
– sequence: 11
  givenname: Yuko
  surname: Kaneko
  fullname: Kaneko, Yuko
– sequence: 12
  givenname: Hidekata
  surname: Yasuoka
  fullname: Yasuoka, Hidekata
– sequence: 13
  givenname: Kunihiro
  surname: Yamaoka
  fullname: Yamaoka, Kunihiro
– sequence: 14
  givenname: Akihiko
  surname: Yoshimura
  fullname: Yoshimura, Akihiko
– sequence: 15
  givenname: Tsutomu
  surname: Takeuchi
  fullname: Takeuchi, Tsutomu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30630515$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAQxyNURB_wAbigSFy4pPgV27kgVRWPSpU4AGdr1nF2vUrsxXb6EF-e2W4p3QohH8Ya_-bvmdH_uDoIMbiqek3JKaVavs-UE9U2hOqGasKam2fVERVKN5JLdvDoflgd57wmhLGOiRfVISeSk5a2R9Wvb34Z_OAthFJDztF6KD6GeuHKtXOhXkePL_NYEuQY4jLBZuVtvYEEkysu5RpCX-fbEK88jLUPwwjTBCWm23oAizFjsk4rN2-zvq8hlVXyxeeX1fMBxuxe3ceT6senj9_PvzSXXz9fnJ9dNlYyWZoOWiqBWsVcP4hW8p53PQEluGqp1bxTWismoedW6IWgVLYtAQJMyIUiQvKT6mKn20dYm03yE6RbE8Gbu0RMS4M9eTs6g8octHSkX3DROaKpJZIpLoHxtrUKtT7stDbzYnK9dQEXM-6J7r8EvzLLeGUkZ0rIDgXe3Quk-HN2uZjJZ-vGEYKLczaMqo5zIQRB9O0TdB3nFHBVSEktpNCq-0stAQfA_Uf8125FzVmrqSCCcobU6T8oPL2bvEVbDR7zewVvHg_6MOEf6yBAd4BNMefkhgeEErO1p9nZ06A9zdae5gZr1JMa68ud37AbP_6n8jfapunb
CitedBy_id crossref_primary_10_1155_2020_4121524
crossref_primary_10_1080_14737159_2020_1707671
crossref_primary_10_1007_s00296_022_05256_4
crossref_primary_10_1093_rheumatology_keab504
crossref_primary_10_1186_s13052_025_01937_5
crossref_primary_10_1021_acscombsci_0c00169
crossref_primary_10_2478_rir_2022_0010
crossref_primary_10_1055_s_0044_1785471
crossref_primary_10_1080_14397595_2020_1847754
crossref_primary_10_14412_1996_7012_2023_3_76_81
crossref_primary_10_1111_1756_185X_13653
crossref_primary_10_1016_j_ejr_2022_08_002
crossref_primary_10_1007_s11596_020_2302_1
Cites_doi 10.1136/annrheumdis-2012-202197
10.1016/S0278-2391(98)90868-0
10.1148/radiol.2251011272
10.1007/s11926-011-0201-y
10.1136/annrheumdis-2013-204603
10.1136/ard.2005.051250
10.1136/annrheumdis-2017-211458
10.1002/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C
10.1002/art.39235
10.1002/art.22296
10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0
10.1186/ar3293
10.1136/annrheumdis-2012-202669
10.1093/rheumatology/kep125
10.1186/ar3280
10.1002/art.10747
10.1186/s13075-015-0567-8
10.1080/14397595.2017.1337056
10.1111/j.1749-6632.2009.04388.x
10.1093/rheumatology/ket311
10.1002/art.1780330302
10.1136/ard.61.10.877
10.1097/BOR.0b013e32835fd8eb
10.3899/jrheum.130556
10.1136/ard.2004.023929
10.1136/ard.2005.051235
10.1136/ard.2010.138461
10.1002/acr.22303
10.1186/ar582
10.1002/art.1780310302
10.1136/ard.2009.117341
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13075-018-1802-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 8
ExternalDocumentID oai_doaj_org_article_39d3a86e0db349e081c062736a2355c7
PMC6327469
A581404132
30630515
10_1186_s13075_018_1802_x
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan
  grantid: 25461484
– fundername: ;
  grantid: 25461484
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
IAO
IHR
NPM
Z7U
PMFND
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c626t-9a516a1c72edf4563d39d0a743751c839788726ad3c48b4116550a0a246b70463
IEDL.DBID 7X7
ISSN 1478-6362
1478-6354
IngestDate Wed Aug 27 01:07:09 EDT 2025
Thu Aug 21 13:41:31 EDT 2025
Thu Jul 10 17:11:50 EDT 2025
Fri Jul 25 22:21:42 EDT 2025
Tue Jun 17 21:46:29 EDT 2025
Tue Jun 10 20:29:01 EDT 2025
Thu Jan 02 22:58:46 EST 2025
Thu Apr 24 23:12:33 EDT 2025
Tue Jul 01 04:00:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Rheumatoid arthritis/DG
Diagnostic imaging
Inflammation
Cytokines
Ultrasonography
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c626t-9a516a1c72edf4563d39d0a743751c839788726ad3c48b4116550a0a246b70463
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2168464879?pq-origsite=%requestingapplication%
PMID 30630515
PQID 2168464879
PQPubID 42876
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_39d3a86e0db349e081c062736a2355c7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6327469
proquest_miscellaneous_2179334440
proquest_journals_2168464879
gale_infotracmisc_A581404132
gale_infotracacademiconefile_A581404132
pubmed_primary_30630515
crossref_primary_10_1186_s13075_018_1802_x
crossref_citationtrail_10_1186_s13075_018_1802_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-10
PublicationDateYYYYMMDD 2019-01-10
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-10
  day: 10
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References M Carotti (1802_CR32) 2002; 61
WP Arend (1802_CR20) 1990; 33
M Walther (1802_CR10) 2002; 225
J Fukae (1802_CR15) 2014; 53
FC Arnett (1802_CR25) 1988; 31
C Pitzalis (1802_CR12) 2013; 25
K Ikeda (1802_CR5) 2013; 40
S Ohrndorf (1802_CR30) 2013; 72
R Kokebie (1802_CR21) 2011; 13
JM Koski (1802_CR28) 2006; 65
PC Taylor (1802_CR33) 2002; 4
R Caporali (1802_CR19) 2018; 77
M Walther (1802_CR13) 2001; 44
S Bugatti (1802_CR17) 2011; 13
E Naredo (1802_CR31) 2005; 64
D Aletaha (1802_CR26) 2010; 69
RJ Wakefield (1802_CR1) 2005; 32
J Strunk (1802_CR3) 2004; 31
M Szkudlarek (1802_CR27) 2001; 44
F Humby (1802_CR9) 2015; 67
HJ Ham van den (1802_CR24) 2009; 48
MA Karsdal (1802_CR23) 2011; 13
JM Koski (1802_CR11) 2006; 65
S Kelly (1802_CR14) 2015; 17
Y Tanaka (1802_CR34) 2018; 28
E Kubota (1802_CR22) 1998; 56
JH Ju (1802_CR4) 2007; 56
PG Conaghan (1802_CR2) 2003; 48
B Saleem (1802_CR8) 2010; 69
K Takase (1802_CR18) 2012; 30
M Andersen (1802_CR16) 2014; 73
M Backhous (1802_CR7) 2009; 1154
T Iwamoto (1802_CR6) 2014; 66
S Kelly (1802_CR29) 2015; 74
References_xml – volume: 72
  start-page: 69
  year: 2013
  ident: 1802_CR30
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202197
– volume: 56
  start-page: 192
  year: 1998
  ident: 1802_CR22
  publication-title: J Oral Maxillofac Surg
  doi: 10.1016/S0278-2391(98)90868-0
– volume: 225
  start-page: 225
  year: 2002
  ident: 1802_CR10
  publication-title: Radiology
  doi: 10.1148/radiol.2251011272
– volume: 13
  start-page: 440
  year: 2011
  ident: 1802_CR17
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-011-0201-y
– volume: 74
  start-page: 611
  year: 2015
  ident: 1802_CR29
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204603
– volume: 65
  start-page: 1658
  year: 2006
  ident: 1802_CR28
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2005.051250
– volume: 32
  start-page: 2485
  year: 2005
  ident: 1802_CR1
  publication-title: J Rheumatol
– volume: 30
  start-page: 85
  year: 2012
  ident: 1802_CR18
  publication-title: Clin Exp Rheumatol
– volume: 77
  start-page: 18
  year: 2018
  ident: 1802_CR19
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-211458
– volume: 44
  start-page: 2018
  year: 2001
  ident: 1802_CR27
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C
– volume: 67
  start-page: 2601
  year: 2015
  ident: 1802_CR9
  publication-title: Arthritis Rheum
  doi: 10.1002/art.39235
– volume: 56
  start-page: 214
  year: 2007
  ident: 1802_CR4
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22296
– volume: 44
  start-page: 331
  year: 2001
  ident: 1802_CR13
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0
– volume: 13
  start-page: R50
  year: 2011
  ident: 1802_CR21
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3293
– volume: 73
  start-page: 678
  year: 2014
  ident: 1802_CR16
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202669
– volume: 48
  start-page: 899
  year: 2009
  ident: 1802_CR24
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep125
– volume: 13
  start-page: 215
  year: 2011
  ident: 1802_CR23
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3280
– volume: 48
  start-page: 64
  year: 2003
  ident: 1802_CR2
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10747
– volume: 17
  start-page: 58
  year: 2015
  ident: 1802_CR14
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0567-8
– volume: 28
  start-page: 58
  year: 2018
  ident: 1802_CR34
  publication-title: Mod Rheumatol
  doi: 10.1080/14397595.2017.1337056
– volume: 1154
  start-page: 139
  year: 2009
  ident: 1802_CR7
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2009.04388.x
– volume: 53
  start-page: 586
  year: 2014
  ident: 1802_CR15
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ket311
– volume: 33
  start-page: 305
  year: 1990
  ident: 1802_CR20
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780330302
– volume: 61
  start-page: 877
  year: 2002
  ident: 1802_CR32
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.61.10.877
– volume: 25
  start-page: 334
  year: 2013
  ident: 1802_CR12
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e32835fd8eb
– volume: 40
  start-page: 1967
  year: 2013
  ident: 1802_CR5
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.130556
– volume: 64
  start-page: 375
  year: 2005
  ident: 1802_CR31
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.023929
– volume: 31
  start-page: 1004
  year: 2004
  ident: 1802_CR3
  publication-title: J Rheumatol
– volume: 65
  start-page: 1590
  year: 2006
  ident: 1802_CR11
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2005.051235
– volume: 69
  start-page: 1580
  year: 2010
  ident: 1802_CR26
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.138461
– volume: 66
  start-page: 1576
  year: 2014
  ident: 1802_CR6
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22303
– volume: 4
  start-page: S99
  issue: Suppl 3
  year: 2002
  ident: 1802_CR33
  publication-title: Arthritis Res
  doi: 10.1186/ar582
– volume: 31
  start-page: 315
  year: 1988
  ident: 1802_CR25
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780310302
– volume: 69
  start-page: 1636
  year: 2010
  ident: 1802_CR8
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.117341
SSID ssj0022924
Score 2.341534
Snippet Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to...
Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD)...
Abstract Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 14
SubjectTerms Aged
Arthritis
Arthritis, Rheumatoid - diagnostic imaging
Arthritis, Rheumatoid - metabolism
Blood & organ donations
Blood flow
Care and treatment
Classification
Cytokines
Cytokines - metabolism
Diagnosis
Diagnostic imaging
Endothelial growth factors
Endothelium
Female
Humans
Hypertrophy
Inflammation
Inflammation Mediators - metabolism
Joint surgery
Knee
Knee Joint - diagnostic imaging
Knee Joint - metabolism
Lymphocytes
Male
Medical diagnosis
Middle Aged
Rheumatism
Rheumatoid arthritis
Rheumatoid arthritis/DG
Rheumatoid factor
Rheumatology
Synovial Fluid - metabolism
Ultrasonic imaging
Ultrasonography
Ultrasound imaging
Vascular endothelial growth factor
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA7SB_FFvDtaJYIgCEPnkts8VrEUob5ooW8hk2TdkXa2dHelpX_e78xk1x0EffE1l2Fyzsm5kC9fGHtrlNRlEITza0UudNB5o4LJo4sB4dAIOVwUPvmijk_F5zN5tvPUF2HCRnrgUXAHdRNqZ1QsQluLJiKCeWLWrZWrECr9cI8cMW9TTKVSq0JZkc4wS6MOlvDUmkBqqJgMXMD1JAoNZP1_uuSdmDTFS-4EoKMH7H7KHPnh-McP2Z3YP2J3T9LZ-GN2-7X73hPwB7Li7rfUeYJi8R-LDj3rc3wcSfZIVd15TuTfFwSKWXLXB7686Rc_YZQcpgdruRhO4Xl6lgeN_Goe19TaBQ7pzQdSpCfs9OjTt4_HeXpaIfeoYFZ542SpXOl1FcMMOVQdIOfCIZ3QsvRImghkWCkXai9MK4ijRxaucJVQrSaSsadsr1_08TnjrpgZF10lYzOD1zVOqTCTTfBBIjiWIWPFRtTWJ95xev7i3A71h1F21I6Fdixpx15n7P12yuVIuvG3wR9If9uBxJc9NMCKbLIi-y8rytg70r6lXY2f8y5dTsASiR_LHkpiBkPArzK2PxmJ3ein3Rv7sckbLG1VKqR5KA2bjL3ZdtNMQrj1cbGmMfCUtRCiyNiz0dy2S6qJGA2JZ8b0xBAna5729N184ApXdaWFal78DyG9ZPeQLhK8DsF7n-2trtbxFVKyVft62H2_AFi0Mzw
  priority: 102
  providerName: Directory of Open Access Journals
Title Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis
URI https://www.ncbi.nlm.nih.gov/pubmed/30630515
https://www.proquest.com/docview/2168464879
https://www.proquest.com/docview/2179334440
https://pubmed.ncbi.nlm.nih.gov/PMC6327469
https://doaj.org/article/39d3a86e0db349e081c062736a2355c7
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0nfdposKhULBxA-9fCqbkhAKCaXtwt6ELGmzLomd7qOk9M93RtbuxhRy8UGSjeUZzXwjjb8h5L0SXOaOYZ5fzVImnUwr4VTqjXfgDhXj4Ufhs3NxOmFfpnwaN9yWMa1yYxODoXadxT3ywyIX4CoBXlefrn-lWDUKT1djCY37ZB-py1Cr5XQXcBVVX9SWQaQEjpXFU81cicMl2G6JaWsQQykwCjcDvxTo-_830re81DCD8pZLOnlMHkUsSce98J-Qe759Sh6cxdPyZ-Tv9-aixVQg-HrU7ORAY3IW_dk10LO-hIcD7O7JqxtLkQ78CtNkltS0ji7_tN1vUFMKygj6cxXO5Wks1AONdDH3a2xtHAVFnAeapOdkcnL84_NpGostpBZimlVaGZ4Lk1tZeDcDVFW6snKZAYAheW4BRmHaYSGMKy1TNUPWHp6ZzBRM1BJpx16QvbZr_StCTTZTxpuC-2oGdlgZIdyMV846Du4ydwnJNp9a28hEjgUxLnWISJTQvXQ0SEejdPRNQj5ub7nuaTjuGnyE8tsORAbt0NAtLnRckBpmVxolfObqklUekJFFxuZSmAIgmJUJ-YDS17jO4eWsib8rwBSRMUuPOXKFAQQoEnIwGAnr0w67N_qjo31Y6p02J-TdthvvxJy31ndrHAO2s2SMZQl52avbdkolUqUBFE2IHCjiYM7DnraZB_ZwURaSier13a_1hjwEaIipdOCoD8jearH2bwF-repRWGMjsn90fP712yhsYsB1Uoz_AQw6MUA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMEChgJhIQUNXEcOzkgVB7VlnZ7oZX2Zhzb213UJmUf0Ir_xG9kJsnuNkLqrVfbieKd8Xyf1-NvAF5nMlWxE5TnV4hQKKfCXLos9MY7hMNMpPVF4f6B7B2Jr4N0sAZ_F3dhKK1yERPrQO0qS_-Rb_FYIlQivc4_nP0MqWoUna4uSmg0brHnL37jlm36fvcz2vcN5ztfDj_1wraqQGiRvM_C3KSxNLFV3Lsh0ofEJbmLDCKpSmOLfIHy67g0LrEiKwTJ06SRiQwXslCkr4XvvQE3EXgj2uypwWqDx_OmiK7AnRkCuWhPUeNMbk0RKxSlyeGeLcMgdN7BwbpcwP-gcAkVuxmblyBw5x7cbbkr226c7T6s-fIB3Oq3p_MP4c-38XFJqUdoLWZWdmdtMhj7UY2xZ36CL0ea34hljy0j-fFTSsuZMlM6Nr0oq1-4LBg6P_rraZ0HwNrCQNjIJiM_p9axY-j4o1qW6REcXYsZHsN6WZX-CTATDTPjDU99PsS4nxkp3TDNnXUpwnPsAogWP7W2rfI5FeA40fUOKJO6sY5G62iyjj4P4N3ykbNG9uOqwR_JfsuBpNhdN1STY90GAI2zS0wmfeSKROQemZglhehEGo6Uz6oA3pL1NcUV_Dhr2usROEVS6NLbKWmTIeXgAWx2RmI8sN3uhf_oNh5N9Wr1BPBq2U1PUo5d6as5jcFYnQghogA2GndbTikhaTakvgGojiN25tztKcejWq1cJlwJmT-9-rNewu3eYX9f7-8e7D2DO0hLKY0PScImrM8mc_8cqd-seFGvNwbfr3uB_wN_QWfF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+association+between+joint+ultrasonographic+parameters+and+synovial+inflammatory+factors+in+rheumatoid+arthritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Kondo%2C+Yasushi&rft.au=Suzuki%2C+Katsuya&rft.au=Inoue%2C+Yumiko&rft.au=Sakata%2C+Koumei&rft.date=2019-01-10&rft.pub=BioMed+Central&rft.issn=1478-6354&rft.eissn=1478-6362&rft.volume=21&rft_id=info:doi/10.1186%2Fs13075-018-1802-x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon